Acumen Pharmaceuticals Stock Filter Stocks by Fundamentals
ABOS Stock | USD 1.57 0.03 1.88% |
Acumen Pharmaceuticals fundamentals help investors to digest information that contributes to Acumen Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Acumen Stock. The fundamental analysis module provides a way to measure Acumen Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Acumen Pharmaceuticals stock.
Acumen | Shares Owned by Institutions |
Acumen Pharmaceuticals Institutional Holders
Institutional Holdings refers to the ownership stake in Acumen Pharmaceuticals that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Acumen Pharmaceuticals' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Acumen Pharmaceuticals' value.Shares | Geode Capital Management, Llc | 2024-09-30 | 864.5 K | T. Rowe Price Associates, Inc. | 2024-09-30 | 849.6 K | Hudson Bay Capital Management Lp | 2024-09-30 | 636 K | Pathstone Holdings Llc | 2024-09-30 | 517.3 K | State Street Corp | 2024-09-30 | 516.4 K | Jane Street Group Llc | 2024-09-30 | 487.6 K | Two Sigma Advisers, Llc | 2024-09-30 | 469.1 K | Two Sigma Investments Llc | 2024-09-30 | 309.5 K | Northern Trust Corp | 2024-09-30 | 308.9 K | Ra Capital Management, Llc | 14.9 M | Franklin Resources Inc | 2024-09-30 | 3.5 M |
Acumen Fundamentals
Return On Equity | -0.33 | ||||
Return On Asset | -0.21 | ||||
Current Valuation | (77.55 M) | ||||
Shares Outstanding | 60.08 M | ||||
Shares Owned By Insiders | 11.23 % | ||||
Shares Owned By Institutions | 78.48 % | ||||
Number Of Shares Shorted | 1.83 M | ||||
Price To Book | 0.43 X | ||||
Price To Sales | 538.78 X | ||||
Gross Profit | (72.52 M) | ||||
EBITDA | (51.61 M) | ||||
Net Income | (52.37 M) | ||||
Cash And Equivalents | 189.91 M | ||||
Cash Per Share | 4.69 X | ||||
Total Debt | 28.49 M | ||||
Current Ratio | 37.21 X | ||||
Book Value Per Share | 3.62 X | ||||
Cash Flow From Operations | (43.06 M) | ||||
Short Ratio | 4.48 X | ||||
Earnings Per Share | (1.38) X | ||||
Price To Earnings To Growth | (0.23) X | ||||
Target Price | 10.8 | ||||
Number Of Employees | 51 | ||||
Beta | 0.039 | ||||
Market Capitalization | 94.33 M | ||||
Total Asset | 310.12 M | ||||
Retained Earnings | (222.8 M) | ||||
Working Capital | 233.64 M | ||||
Net Asset | 310.12 M |
About Acumen Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Acumen Pharmaceuticals's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Acumen Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Acumen Pharmaceuticals based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Acumen Stock Analysis
When running Acumen Pharmaceuticals' price analysis, check to measure Acumen Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Acumen Pharmaceuticals is operating at the current time. Most of Acumen Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Acumen Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Acumen Pharmaceuticals' price. Additionally, you may evaluate how the addition of Acumen Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.